{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:32:09Z","timestamp":1794544329112,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473107"],"award-info":[{"award-number":["82473107"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102984"],"award-info":[{"award-number":["82102984"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,1,29]]},"DOI":"10.1038\/s41388-025-03655-y","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T07:52:25Z","timestamp":1765093945000},"page":"339-351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["RBM8A confers oxaliplatin resistance in gastric cancer by maintaining EGFR mRNA stability"],"prefix":"10.1038","volume":"45","author":[{"given":"Yichun","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueni","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinya","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongji","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangtao","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linzhe","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangtao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangmei","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3959-4542","authenticated-orcid":false,"given":"Zhangding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"3655_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA A Cancer J Clin"},{"key":"3655_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, Van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"3655_CR3","doi-asserted-by":"publisher","first-page":"7829","DOI":"10.1039\/C5CS00316D","volume":"44","author":"S Liu","year":"2015","unstructured":"Liu S, Wang Y. Mass spectrometry for the assessment of the occurrence and biological consequences of DNA adducts. Chem Soc Rev. 2015;44:7829\u201354.","journal-title":"Chem Soc Rev"},{"key":"3655_CR4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1039\/c1mt00041a","volume":"3","author":"A Zayed","year":"2011","unstructured":"Zayed A, Jones GDD, Reid HJ, Shoeib T, Taylor SE, Thomas AL, et al. Speciation of oxaliplatin adducts with DNA nucleotides. Metallomics. 2011;3:991.","journal-title":"Metallomics"},{"key":"3655_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315\u201321.","journal-title":"Lancet"},{"key":"3655_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.biocel.2017.08.001","volume":"92","author":"Q Wang","year":"2017","unstructured":"Wang Q, Xiong J, Qiu D, Zhao X, Yan D, Xu W, et al. Inhibition of PARP1 activity enhances chemotherapeutic efficiency in cisplatin-resistant gastric cancer cells. Int J Biochem Cell Biol. 2017;92:164\u201372.","journal-title":"Int J Biochem Cell Biol"},{"key":"3655_CR7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41576-022-00550-0","volume":"24","author":"S He","year":"2023","unstructured":"He S, Valkov E, Cheloufi S, Murn J. The nexus between RNA-binding proteins and their effectors. Nat Rev Genet. 2023;24:276\u201394.","journal-title":"Nat Rev Genet"},{"key":"3655_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106593","volume":"187","author":"H Han","year":"2023","unstructured":"Han H, Lin T, Wang Z, Song J, Fang Z, Zhang J, et al. RNA-binding motif 4 promotes angiogenesis in HCC by selectively activating VEGF-A expression. Pharmacol Res. 2023;187:106593.","journal-title":"Pharmacol Res"},{"key":"3655_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41388-023-02902-4","volume":"43","author":"C Wang","year":"2024","unstructured":"Wang C, Chen Z, Yi Y, Ding Y, Xu F, Kang H, et al. RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1\/ACSL4. Oncogene. 2024;43:328\u201340.","journal-title":"Oncogene"},{"key":"3655_CR10","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1038\/s41388-024-03140-y","volume":"43","author":"H Han","year":"2024","unstructured":"Han H, Shi Q, Zhang Y, Ding M, He X, Liu C, et al. RBM12 drives PD-L1-mediated immune evasion in hepatocellular carcinoma by increasing JAK1 mRNA translation. Oncogene. 2024;43:3062\u201377.","journal-title":"Oncogene"},{"key":"3655_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ebiom.2019.06.017","volume":"45","author":"F Li","year":"2019","unstructured":"Li F, Zhao H, Su M, Xie W, Fang Y, Du Y, et al. HnRNP-F regulates EMT in bladder cancer by mediating the stabilization of Snail1 mRNA by binding to its 3\u2032 UTR. EBioMedicine. 2019;45:208\u201319.","journal-title":"EBioMedicine"},{"key":"3655_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ebiom.2019.02.059","volume":"41","author":"TM Chen","year":"2019","unstructured":"Chen TM, Lai MC, Li YH, Chan YL, Wu CH, Wang YM, et al. hnRNPM induces translation switch under hypoxia to promote colon cancer development. EBioMedicine. 2019;41:299\u2013309.","journal-title":"EBioMedicine"},{"key":"3655_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217191","volume":"604","author":"H Han","year":"2024","unstructured":"Han H, Yuan Y, Li C, Liu L, Yu H, Han G, et al. RNA-binding motif protein 28 enhances angiogenesis by improving STAT3 translation in hepatocellular carcinoma. Cancer Lett. 2024;604:217191.","journal-title":"Cancer Lett"},{"key":"3655_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01459-1","volume":"9","author":"A Xia","year":"2023","unstructured":"Xia A, Yue Q, Zhu M, Xu J, Liu S, Wu Y, et al. The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination. Cell Death Discov. 2023;9:169.","journal-title":"Cell Death Discov"},{"key":"3655_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13117","volume":"54","author":"Z Wang","year":"2021","unstructured":"Wang Z, Fu Y, Xia A, Chen C, Qu J, Xu G, et al. Prognostic and predictive role of a metabolic rate-limiting enzyme signature in hepatocellular carcinoma. Cell Prolif. 2021;54:e13117.","journal-title":"Cell Prolif"},{"key":"3655_CR16","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.3390\/ijms26073127","volume":"26","author":"M Nakahara","year":"2025","unstructured":"Nakahara M, Arai R, Tokuoka I, Fukumura K, Mayeda A, Yashiro M, et al. RBM17 Promotes the Chemoresistance of Oral Squamous Cancer Cells Through Checkpoint Kinase 1. Int J Mol Sci. 2025;26:3127.","journal-title":"Int J Mol Sci"},{"key":"3655_CR17","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.7150\/ijbs.66480","volume":"18","author":"F Xu","year":"2022","unstructured":"Xu F, Xia T, Xu QT, Zhang X, Huang YZ, Sun X, et al. RBMS2 Chemosensitizes Breast Cancer Cells to Doxorubicin by Regulating BMF Expression. Int J Biol Sci. 2022;18:1724\u201336.","journal-title":"Int J Biol Sci"},{"key":"3655_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41388-024-03220-z","volume":"44","author":"H Li","year":"2025","unstructured":"Li H, Li Y, Zheng X, Chen F, Zhang S, Xu S, et al. RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1. Oncogene. 2025;44:307\u201321.","journal-title":"Oncogene"},{"key":"3655_CR19","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1038\/s41388-025-03475-0","volume":"44","author":"X Zhao","year":"2025","unstructured":"Zhao X, Bao L, Qian Y, Zhou S, Chen C, Ma Z, et al. NNMT-mediated N6-methyladenosine modification of NR4A3 mRNA facilitates lymphatic metastasis of gastric adenocarcinoma. Oncogene. 2025;44:2970\u201382.","journal-title":"Oncogene"},{"key":"3655_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/gutjnl-2022-328408","volume":"73","author":"Z Wang","year":"2024","unstructured":"Wang Z, Wang Q, Chen C, Zhao X, Wang H, Xu L, et al. NNMT enriches for AQP5+ cancer stem cells to drive malignant progression in early gastric cardia adenocarcinoma. Gut. 2024;73:63\u201377.","journal-title":"Gut"},{"key":"3655_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.canlet.2021.07.005","volume":"518","author":"C Chen","year":"2021","unstructured":"Chen C, Shen N, Chen Y, Jiang P, Sun W, Wang Q, et al. LncCCLM inhibits lymphatic metastasis of cervical cancer by promoting STAU1-mediated IGF-1 mRNA degradation. Cancer Lett. 2021;518:169\u201379.","journal-title":"Cancer Lett"},{"key":"3655_CR22","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1158\/0008-5472.CAN-24-0088","volume":"84","author":"Y Pan","year":"2024","unstructured":"Pan Y, Zhou Y, Shen Y, Xu L, Liu H, Zhang N, et al. Hypoxia Stimulates PYGB Enzymatic Activity to Promote Glycogen Metabolism and Cholangiocarcinoma Progression. Cancer Res. 2024;84:3803\u201317.","journal-title":"Cancer Res"},{"key":"3655_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","volume":"20","author":"ST Crooke","year":"2021","unstructured":"Crooke ST, Baker BF, Crooke RM, Liang Xhai. Antisense technology: an overview and prospectus. Nature Rev Drug Discov. 2021;20:427\u201353.","journal-title":"Nature Rev Drug Discov"},{"key":"3655_CR24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1158\/0008-5472.CAN-20-0948","volume":"82","author":"WK Ma","year":"2022","unstructured":"Ma WK, Voss DM, Scharner J, Costa ASH, Lin KT, Jeon HY, et al. ASO-based PKM splice-switching therapy inhibits hepatocellular carcinoma growth. Cancer Res. 2022;82:900\u201315.","journal-title":"Cancer Res"},{"key":"3655_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13046-018-1021-y","volume":"38","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Lu H, Zhu S, Gomaa A, Chen Z, Yan J, et al. Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage. J Exp Clin Cancer Res. 2019;38:13.","journal-title":"J Exp Clin Cancer Res"},{"key":"3655_CR26","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1053\/j.gastro.2014.02.005","volume":"146","author":"R Chaturvedi","year":"2014","unstructured":"Chaturvedi R, Asim M, Piazuelo MB, Yan F, Barry DP, Sierra JC, et al. Activation of EGFR and ERBB2 by Helicobacter pylori Results in Survival of Gastric Epithelial Cells With DNA Damage. Gastroenterology. 2014;146:1739\u20131751.e14.","journal-title":"Gastroenterology"},{"key":"3655_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41419-019-1362-2","volume":"10","author":"L Lin","year":"2019","unstructured":"Lin L, Li X, Pan C, Lin W, Shao R, Liu Y, et al. ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance. Cell Death Dis. 2019;10:173.","journal-title":"Cell Death Dis"},{"key":"3655_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.omtn.2021.07.003","volume":"26","author":"X Wang","year":"2021","unstructured":"Wang X, Chen M, Fang L. hsa_circ_0068631 promotes breast cancer progression through c-Myc by binding to EIF4A3. Molecular Ther - Nucleic Acids. 2021;26:122\u201334.","journal-title":"Molecular Ther - Nucleic Acids"},{"key":"3655_CR29","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","volume":"82","author":"X Jiang","year":"2022","unstructured":"Jiang X, Guo S, Wang S, Zhang Y, Chen H, Wang Y, et al. EIF4A3-Induced circARHGAP29 Promotes Aerobic Glycolysis in Docetaxel-Resistant Prostate Cancer through IGF2BP2\/c-Myc\/LDHA Signaling. Cancer Res. 2022;82:831\u201345.","journal-title":"Cancer Res"},{"key":"3655_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrm.2015.7","volume":"17","author":"HL Hir","year":"2016","unstructured":"Hir HL, Sauli\u00e8re J, Wang Z. The exon junction complex as a node of post-transcriptional networks. Nature Rev Mol Cell Biol. 2016;17:41\u201354.","journal-title":"Nature Rev Mol Cell Biol"},{"key":"3655_CR31","first-page":"5749","volume":"62","author":"AE Wakeling","year":"2002","unstructured":"Wakeling AE, Guy SP, Woodburn JR, Ashton SE, Curry BJ, Barker AJ, et al. ZD1839 (Iressa): An orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res. 2002;62:5749\u201354.","journal-title":"Cancer Res"},{"key":"3655_CR32","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s00432-020-03228-4","volume":"146","author":"A Li","year":"2020","unstructured":"Li A, Cao W, Liu X, Zhang Y, Ma Y, Xu R, et al. Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells. Journal Cancer Res Clin Oncol. 2020;146:1737\u201349.","journal-title":"Journal Cancer Res Clin Oncol"},{"key":"3655_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-4-83","volume":"4","author":"LA Knight","year":"2004","unstructured":"Knight LA, Di Nicolantonio F, Whitehouse P, Mercer S, Sharma S, Glaysher S, et al. The in vitroeffect of gefitinib (\u2018Iressa\u2019) alone and in combination with cytotoxic chemotherapy on human solid tumours. BMC Cancer. 2004;4:83.","journal-title":"BMC Cancer"},{"key":"3655_CR34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41587-020-00795-2","volume":"39","author":"R Gao","year":"2021","unstructured":"Gao R, Bai S, Henderson YC, Lin Y, Schalck A, Yan Y, et al. Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. Nature Biotechnol. 2021;39:599\u2013608.","journal-title":"Nature Biotechnol"},{"key":"3655_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10637-019-00749-9","volume":"38","author":"M Suenaga","year":"2020","unstructured":"Suenaga M, Wakatsuki T, Mashima T, Ogura M, Ichimura T, Shinozaki E, et al. A phase I study to determine the maximum tolerated dose of trifluridine\/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study. Investigational N. Drugs. 2020;38:111\u20139.","journal-title":"Investigational N. Drugs"},{"key":"3655_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2020.03.011","volume":"78","author":"M Corley","year":"2020","unstructured":"Corley M, Burns MC, Yeo GW. How RNA-Binding Proteins Interact with RNA: Molecules and Mechanisms. Molecular Cell. 2020;78:9\u201329.","journal-title":"Molecular Cell"},{"key":"3655_CR37","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/s41388-019-1034-9","volume":"39","author":"JH Jung","year":"2020","unstructured":"Jung JH, Lee H, Cao B, Liao P, Zeng SX, Lu H. RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53. Oncogene. 2020;39:1031\u201340.","journal-title":"Oncogene"},{"key":"3655_CR38","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1177\/1535370213494646","volume":"238","author":"Y Ishigaki","year":"2013","unstructured":"Ishigaki Y, Nakamura Y, Tatsuno T, Hashimoto M, Shimasaki T, Iwabuchi K, et al. Depletion of RNA-binding protein RBM8A (Y14) causes cell cycle deficiency and apoptosis in human cells. Experimental Biol Med. 2013;238:889\u201397.","journal-title":"Experimental Biol Med"},{"key":"3655_CR39","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/biom5020343","volume":"5","author":"TW Chuang","year":"2015","unstructured":"Chuang TW, Lee KM, Tarn WY. Function and Pathological Implications of Exon Junction Complex Factor Y14. Biomolecules. 2015;5:343\u201355.","journal-title":"Biomolecules"},{"key":"3655_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.isci.2019.03.005","volume":"13","author":"TW Chuang","year":"2019","unstructured":"Chuang TW, Lu CC, Su CH, Wu PY, Easwvaran S, Lee CC, et al. The RNA Processing Factor Y14 Participates in DNA Damage Response and Repair. iScience. 2019;13:402\u201315.","journal-title":"iScience"},{"key":"3655_CR41","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1093\/neuonc\/noac105","volume":"24","author":"J Ding","year":"2022","unstructured":"Ding J, Li X, Khan S, Zhang C, Gao F, Sen S, et al. EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma. Neuro-Oncol. 2022;24:1712\u201325.","journal-title":"Neuro-Oncol"},{"key":"3655_CR42","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/0008-5472.CAN-10-2384","volume":"71","author":"G Liccardi","year":"2011","unstructured":"Liccardi G, Hartley JA, Hochhauser D. EGFR Nuclear Translocation Modulates DNA Repair following Cisplatin and Ionizing Radiation Treatment. Cancer Res. 2011;71:1103\u201314.","journal-title":"Cancer Res"},{"key":"3655_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.585452","volume":"10","author":"R Liang","year":"2021","unstructured":"Liang R, Zhang J, Liu Z, Liu Z, Li Q, Luo X, et al. Mechanism and Molecular Network of RBM8A-Mediated Regulation of Oxaliplatin Resistance in Hepatocellular Carcinoma. Front Oncol. 2021;10:585452.","journal-title":"Front Oncol"},{"key":"3655_CR44","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nsmb990","volume":"12","author":"L Ballut","year":"2005","unstructured":"Ballut L, Marchadier B, Baguet A, Tomasetto C, S\u00e9raphin B, Le Hir H. The exon junction core complex is locked onto RNA by inhibition of eIF4AIII ATPase activity. Nature Struct Mol Biol. 2005;12:861\u20139.","journal-title":"Nature Struct Mol Biol"},{"key":"3655_CR45","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1017\/S1355838202021088","volume":"8","author":"MS Jurica","year":"2002","unstructured":"Jurica MS, Licklider LJ, Gygi SP, Grigorieff N, Moore MJ. Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. RNA. 2002;8:426\u201339.","journal-title":"RNA"},{"key":"3655_CR46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/neuonc\/noaa214","volume":"23","author":"Y Wei","year":"2021","unstructured":"Wei Y, Lu C, Zhou P, Zhao L, Lyu X, Yin J, et al. EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS\/MEK1\/ERK1\u20132 signaling. Neuro-Oncol. 2021;23:611\u201324.","journal-title":"Neuro-Oncol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03655-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03655-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03655-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T13:47:35Z","timestamp":1766584055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03655-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,29]]}},"alternative-id":["3655"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03655-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal related experiments were approved by the Animal Care and Use Committee of Nanjing Drum Tower Hospital. All participants were fully aware of the goal and possible risk of this study and provided written informed consent. This study was performed in accordance with the Declaration of Helsinki principles.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}